Hikma Pharmaceuticals PLC 2025 Annual Report with Sustainability Disclosures
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 113
The report describes Hikma's completed Group-level double materiality assessment and refreshed four-pillar sustainability framework. It reports a 16% reduction in market-based Scope 1 and 2 emissions since 2020, alongside a 25% reduction target by 2030. The report also highlights 262 million patients treated in 2024, 566,780 community beneficiaries, and $2.6m of medicines donated in 2025.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.